Southern Acids (M) Berhad Management

Management Kriterienprüfungen 3/4

Southern Acids (M) Berhad's CEO ist Nick Low , ernannt in Jul 2015, hat eine Amtszeit von 9.08 Jahren. Die jährliche Gesamtvergütung beträgt MYR941.88K , bestehend aus 54.4% Gehalt und 45.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.071% der Aktien des Unternehmens, im Wert von MYR325.01K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 10.8 Jahre bzw. 9.5 Jahre.

Wichtige Informationen

Nick Low

Geschäftsführender

RM 941.9k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	54.4%
Amtszeit als Geschäftsführer	9.3yrs
Eigentum des Geschäftsführers	0.07%
Durchschnittliche Amtszeit des Managements	11yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	9.7yrs

Jüngste Management Updates

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Nick Low im Vergleich zu den Einnahmen von Southern Acids (M) Berhad verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	RM 6m
Mar 31 2024	RM 942k	RM 512k	RM 14m
Dec 31 2023	n/a	n/a	-RM 1m
Sep 30 2023	n/a	n/a	RM 11m
Jun 30 2023	n/a	n/a	RM 28m
Mar 31 2023	RM 927k	RM 505k	RM 33m
Dec 31 2022	n/a	n/a	RM 69m
Sep 30 2022	n/a	n/a	RM 80m
Jun 30 2022	n/a	n/a	RM 86m
Mar 31 2022	RM 874k	RM 463k	RM 94m
Dec 31 2021	n/a	n/a	RM 74m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 44m
Mar 31 2021	RM 727k	RM 421k	RM 37m
Dec 31 2020	n/a	n/a	RM 40m
Sep 30 2020	n/a	n/a	RM 44m
Jun 30 2020	n/a	n/a	RM 44m
Mar 31 2020	RM 712k	RM 414k	RM 32m
Dec 31 2019	n/a	n/a	RM 24m
Sep 30 2019	n/a	n/a	RM 19m
Jun 30 2019	n/a	n/a	RM 19m
Mar 31 2019	RM 699k	RM 390k	RM 21m
Dec 31 2018	n/a	n/a	RM 29m
Sep 30 2018	n/a	n/a	RM 35m
Jun 30 2018	n/a	n/a	RM 32m
Mar 31 2018	RM 649k	RM 366k	RM 33m

Vergütung im Vergleich zum Markt: NickDie Gesamtvergütung ($USD197.91K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MY ($USD105.97K).

Entschädigung vs. Einkommen: NickDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Nick Low (45 yo)

9.3yrs

Amtszeit

RM 941,877

Vergütung

Dr. Kok Thye Low , also known as Nick, has been Managing Director and Director of Southern Acids M Bhd since July 2015. Dr. Low served as a Director In-Lead of Oleochemical and Health Care Divisions at Sou...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 302.5k
Kim Lim	Non-Independent Executive Director	16.2yrs	RM 759.05k	2.32% MYR 10.2m
Kee Cheong	Chief Financial Officer	11yrs	keine Daten	keine Daten
Thevakumar Kaliaperumal	General Manager of Operations	1.8yrs	keine Daten	keine Daten
Chuu Tiong	Chief Operating Officer of Oleochemical Manufacturing Segment	13.8yrs	keine Daten	keine Daten
Choon Chan	Chief Strategic Development Officer	no data	keine Daten	keine Daten
Kui Lim	Company Secretary	16.2yrs	keine Daten	keine Daten
Shu Ng	Company Secretary	1.6yrs	keine Daten	keine Daten

11.0yrs

Durchschnittliche Betriebszugehörigkeit

54.5yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von SAB ist erfahren und erfahren (durchschnittliche Amtszeit: 10.2 Jahre).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 302.5k
Kim Lim	Non-Independent Executive Director	19.2yrs	RM 759.05k	2.32% MYR 10.2m
Kin Chung	Non Independent Non Executive Director	12.6yrs	RM 150.45k	keine Daten
Sulong bin Matjeraie	Independent Non-Executive Chairman	10.2yrs	RM 151.80k	keine Daten
Yeng Wan	Independent & Non Executive Director	1.6yrs	RM 104.95k	keine Daten
Deborah Choa	Independent Non-Executive Director	1.2yrs	RM 55.38k	keine Daten

9.7yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrener Vorstand: SABDie Vorstandsmitglieder gelten als erfahren (8.9 Jahre durchschnittliche Amtszeit).

Southern Acids (M) Berhad Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Recent updates

New major risk - Revenue and earnings growth

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter